title: Cytokines, molecular biological abnormalities, and acute myelogenous leukemia.
abstract: Leukemia cell proliferation is dependent upon cytokines produced by the leukemia cells or by the microenvironment under stimulation by leukemia cells. Abnormal expression of the p53, rb, and ras genes is associated with cytokine production, suggesting that abnormal expression can affect leukemia cells by affecting intracellular growth controls and by stimulating cytokine production. While these observations suggest that cytokines can be used to stimulate leukemia proliferation during cytotoxic therapy increasing the sensitivity to treatment, they also suggest that inhibition of cytokine affects could increase clinical responses by reducing leukemia cell regrowth between courses of therapy.
authors.affiliation: Rush-Presbyterian-St-Luke's Medical Center, Rush Cancer Institute, Chicago, IL 60612, USA.
authors.forename: H D
authors.initials: HD
authors.lastname: Preisler
authors.forename: S
authors.initials: S
authors.lastname: Bi
authors.forename: P
authors.initials: P
authors.lastname: Venugopal
authors.forename: A
authors.initials: A
authors.lastname: Raza
mesh_terms: D000818:Animals; D016207:Cytokines / Q000235:genetics*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*
chemical_list: D016207:Cytokines